Asthma News and Research RSS Feed - Asthma News and Research Twitter

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

When asthmatics come into contact with something that irritates their lungs, three main changes occur that prevent air from moving easily through the airways. The bands of muscle surrounding the airways tighten and narrow the airway (bronchospasm), the lining of the airways inflame, and the cells that line the airways produce more mucus. This bronchospasm, inflammation, and mucus production lead to wheezing, coughing and difficulty in breathing.

An asthma “attack” refers to when the onset of symptoms is severe. In rare cases, an asthma attack can be life threatening and hospitalization may be required to provide emergency treatment.
The exact cause of asthma is not yet clear, but examples of factors that are known to trigger the condition include allergens such as house dust mites or pollen, cigarette smoke, exercise, chest infections, and exposure to cold air.

Asthma cannot be cured but it can be controlled. One of the most important parts of asthma control is identifying asthma triggers so they can be avoided wherever possible. Medications that may be used include anti-inflammatories to reduce swelling and mucus production and bronchodilators to relax the muscles that tighten and narrow the airways.
Parents need to take active role in oral health of children

Parents need to take active role in oral health of children

February is National Children's Dental Health Month, an opportunity for parents of toddlers, young children or teenagers to explore questions about keeping your child's teeth clean, your child's first dental visit or how to protect children's smiles. [More]
Lupin Pharmaceuticals releases Metformin HCl ER Tablets

Lupin Pharmaceuticals releases Metformin HCl ER Tablets

Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc., has launched its Metformin HCl ER Tablets, 500 mg and 1000 mg to market a generic equivalent of Santarus Inc.'s Glumetza HCl ER Tablets, 500 mg and 1000 mg. [More]
Experts call for new approach to asthma and COPD patient management

Experts call for new approach to asthma and COPD patient management

Defining a patient's symptoms using the historical diagnostic labels of asthma and chronic obstructive pulmonary disease (COPD) is an outdated approach to understanding an individual's condition, according to experts writing in the European Respiratory Journal today (Feb. 1, 2016). [More]
Increased breastfeeding could save over 800000 children’s lives annually

Increased breastfeeding could save over 800000 children’s lives annually

Just 1 in 5 children in high-income countries are breastfed to 12 months, whilst only 1 in 3 children in low and middle-income countries are exclusively breastfed for the first 6 months. [More]
UAB discovery may offer new therapeutic approaches to asthma

UAB discovery may offer new therapeutic approaches to asthma

University of Alabama at Birmingham researchers have found a previously unknown step in the pathway that leads to asthma, a discovery that may offer new therapeutic approaches to this incurable disease. Asthma affects more than 25 million people in the United States, including about 7 million children. [More]
Immunotherapy could be the future of cancer treatments

Immunotherapy could be the future of cancer treatments

For decades most cancers have been treated with the standard of care treatments which typically include surgery, radiation and/or chemotherapy. Now there is talk that immunotherapy represents "the future of cancer treatments." [More]
Easy access to children's GPs reduces visits to emergency departments

Easy access to children's GPs reduces visits to emergency departments

Children whose GPs are easy to access are less likely to visit A&E than those whose GPs are less able to provide appointments. During weekdays, children's visits to A&E peak after school hours. [More]
Four USF professors selected as AIMBE College of Fellows

Four USF professors selected as AIMBE College of Fellows

Four University of South Florida professors have been elected to the 2016 College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE): Cesario Borlongan and Shyam Mohapatra from the USF Morsani College of Medicine, USF Health; and Robert Frisina, Jr., and Sudeep Sarkar from the USF College of Engineering. [More]
GBI Research says COPD therapeutics pipeline lacks innovation

GBI Research says COPD therapeutics pipeline lacks innovation

Analysis from business intelligence provider GBI Research - Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation - states that while currently-available drugs aim to manage the frequency and severity of symptoms associated with COPD, none have been shown to modify long-term disease progression. [More]
Study explores new approaches to prevent fall asthma exacerbations in pediatric patients

Study explores new approaches to prevent fall asthma exacerbations in pediatric patients

Experts from Children's Hospital Colorado (Children's Colorado) co-led a team of researchers in studying new approaches to reducing fall asthma exacerbations in pediatric patients. [More]
New clinical study reveals previously unknown risk factors linked to keratoconus

New clinical study reveals previously unknown risk factors linked to keratoconus

A large new study reveals previously unknown risk factors associated with an eye condition that causes serious progressive nearsightedness at a relatively young age. [More]
Pulmonary neuroendocrine cells act like sensor to orchestrate immune response

Pulmonary neuroendocrine cells act like sensor to orchestrate immune response

An uncommon and little-studied type of cell in the lungs has been found to act like a sensor, linking the pulmonary and central nervous systems to regulate immune response in reaction to environmental cues. [More]
AlerSense develops world's first smart airborne allergy and asthma early warning system

AlerSense develops world's first smart airborne allergy and asthma early warning system

AlerSense Incorporated has created the world's first smart airborne allergy and asthma early warning system alerting consumers as particles and toxins build. AlerSense is an in-home unit when, combined with the mobile app, delivers accurate environmental readings, giving asthma and allergy sufferers precious time to remove themselves from, or alter the environment to possibly mitigate or avoid an allergy or asthma attack. [More]
UA researchers find genetic mutations associated with respiratory disease

UA researchers find genetic mutations associated with respiratory disease

Asthma affects more than 278 million people worldwide and can lead to serious consequences later in life. While current approved therapies address symptoms, they do not halt disease progression. [More]
FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients. [More]
New class of sound wave could lead to revolution in stem cell therapy

New class of sound wave could lead to revolution in stem cell therapy

Acoustics experts have created a new class of sound wave - the first in more than half a century - in a breakthrough they hope could lead to a revolution in stem cell therapy. [More]
Study shows clear role of bacteria in modulating immune function in the lungs

Study shows clear role of bacteria in modulating immune function in the lungs

Microbiota--the trillions of bacteria that co-exist in the body--regulate the ability of lung dendritic cells to generate immune responses, according to a study led by researchers from the Icahn School of Medicine at Mount Sinai, published online in the Journal of Experimental Medicine. [More]
SDSU researchers explore ways to eradicate thirdhand smoke

SDSU researchers explore ways to eradicate thirdhand smoke

When cigarette smoke is blown into the environment, its chemical constituents don't just vanish into thin air. Residue from the smoke settles into, accumulates and is stored in the surrounding environment, such as upholstery, carpets, walls, clothing and curtains. [More]
Researchers suggest microorganisms in the womb set stage for health problems later in life

Researchers suggest microorganisms in the womb set stage for health problems later in life

Researchers review importance of microorganisms that exist in the gut, suggesting perturbation of the environment during pregnancy, delivery and early infancy could impact the developing baby's early microbiome and set the stage for health problems later in life. The term "microbiome" refers to the trillions of organisms we harbor, on our skin and within our respiratory and gastrointestinal tracts. [More]
Body can control pathogen-induced inflammatory response, find Georgia State researchers

Body can control pathogen-induced inflammatory response, find Georgia State researchers

The body can control inflammatory response triggered by invasions of microbial pathogens, such as bacteria and viruses, a discovery that could lead to the development of new therapeutic agents for uncontrolled inflammation, according to researchers at Georgia State University. [More]
Advertisement